HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galantamine improves gait performance in patients with Alzheimer's disease.

AuthorsFrédéric Assal, Gilles Allali, Reto W Kressig, François R Herrmann, Olivier Beauchet
JournalJournal of the American Geriatrics Society (J Am Geriatr Soc) Vol. 56 Issue 5 Pg. 946-7 (May 2008) ISSN: 1532-5415 [Electronic] United States
PMID18454755 (Publication Type: Controlled Clinical Trial, Letter)
Chemical References
  • Cholinesterase Inhibitors
  • Nootropic Agents
  • Galantamine
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (diagnosis, drug therapy)
  • Attention (drug effects)
  • Cholinesterase Inhibitors (therapeutic use)
  • Female
  • Gait (drug effects)
  • Galantamine (therapeutic use)
  • Humans
  • Male
  • Mental Status Schedule
  • Neurologic Examination (drug effects)
  • Neuropsychological Tests
  • Nootropic Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: